Latest in laser generation

Article

Breaking news from the floor of ESCRS

SCHWIND has launched the new AMARIS 750S laser system, a further development of the AMARIS portfolio of laser systems, now with a pulse frequency of 750 Hz. According to the company, this system will benefit patients with its extremely short treatment time, which is combined with safety features that include the six-dimensional, active 1050 Hz eye tracking.

The system was showcased at a symposium during the congress, where experts shared their experiences of using the new system. Maria C. Arbelaez, from the Muscat Eye Laser Center, Oman, presented the results of a one-month LASIK study of 225 eyes.

The system was used for LASIK aberration-free treatments for myopia and myopic astigmatism. For the type of procedure used, the ablation times per dioptre were found to be much lower compared to the market median. After one month 85% of treated eyes have achieved the planned refractive outcome with a minimal deviation of a quarter of a dioptre and 100% were within half a dioptre. Despite the short follow-up time, the study concluded that results so far imply the recovery after treatment is very short and that the system shows excellent performance.

Alfred Vogeland Thomas Kohnen presented a new concept laser system that the company claims could mean a paradigm shift in refractive and therapeutic corneal surgery; the multifunctional and mobile SmartTech Laser. The laser system is based on nanosecond laser technology and uses the principle of plasma creation for separation of the corneal tissue. The focal spot is reported to be one-third the size of standard femtosecond lasers, which the studies found, along with the short wavelength in the UV range and aberration-free optical system, resulted in extreme precision.

Further details of the symposium will appear in a future issue of Ophthalmology Times Europe.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.